Myristin is the U.S. patented Cetyl Myristoleate supplement

Harry W. Diehl discovered cetyl myristoleate (CMO) in 1964 in his home laboratory. While he was employed then at the National Institutes of Health in Bethesda, Maryland, CMO was his personal, off-duty project. He received a U.S. patent on CMO initially in 1977 (U.S. Patent #4,049,824). He later received an entirely new patent in 1996 (U.S. Patent #5,569,676). Mr. Diehl tried unsuccessfully to get some large companies, such as Pfizer and Merck, to accept his discovery for research and marketing but they declined, possibly due to rules concerning patents on natural products. Despite owning these two patents, Mr. Diehl was unfamiliar with the marketing of natural products, so, unfortunately, CMO remained unknown to users of natural products until 1996.

EHP Products, Inc. was founded in 1995 by Elaine Parrish, Mr. Diehl's daughter. Mr. Diehl wanted to assure a way for this astounding discovery to reach the public in his original oil formula, and Elaine was willing to form a company to distribute his formula of cetyl myristoleate which EHP Products Inc. tradenamed Myristin®. In 1996, Mr. Diehl assigned his most recent patent to EHP Products. Myristin Products is the only company in the world to market a 40% CMO softgel.

Myristin Products is proud to have many M.D.'s, D.O.'s, N.D.'s, D.C.'s, D.P.M's, D.V.M's, and other healthcare professionals among its customers. Myristin® Dietary Supplement is marketed in the United States and internationally. EHP ships frequently to such countries as Canada, United Kingdom, France, Philippine Islands, The Netherlands, South Africa, and Australia.